|
Dr. Frank A.G.M. Verwiel of Saint-Bruno-de-Montarville Quebec Canada joined the Corporation as president and chief executive officer in July 2005. He has served on the board of directors of Axcan Pharma Inc. since August 2005.
Dr. Verwiel most recently held the position of vice president hypertension Worldwide Human Health Marketing with Merck & Co. Inc. (Merck) while concurrently serving as a member of Merck's worldwide hypertension business strategy team. He joined Merck in 1996 and was appointed managing director of MSD The Netherlands in 1997.
Prior to joining Merck from 1988 to 1996 Dr. Verwiel worked with les Laboratories Servier in Europe in various executive positions. He holds a Doctorate of Medicine from Erasmus University in Rotterdam The Netherlands and a Master of Business Administration (MBA) from INSEAD in Fontainebleau France. | 